Quercetin, a bioflavonoid, attenuates haloperidol-induced orofacial dyskinesia.
about
Protective effect of curcumin and its combination with piperine (bioavailability enhancer) against haloperidol-associated neurotoxicity: cellular and neurochemical evidence.Redox processes in neurodegenerative disease involving reactive oxygen speciesCrocin prevents haloperidol-induced orofacial dyskinesia: possible an antioxidant mechanismOxidative stress and the antipsychotic-induced vacuous chewing movement model of tardive dyskinesia: evidence for antioxidant-based prevention strategies.α-Lipoic acid interaction with dopamine D2 receptor-dependent activation of the Akt/GSK-3β signaling pathway induced by antipsychotics: potential relevance for the treatment of schizophrenia.Effect of quercetin on lipopolysaccharide induced-sickness behavior and oxidative stress in rats.Protective effect of quercetin in primary neurons against Abeta(1-42): relevance to Alzheimer's diseaseThe selective cyclooxygenase-2 inhibitor, the compound 11b improves haloperidol induced catatonia by enhancing the striatum dopaminergic neurotransmission.Bauhinia forficata prevents vacuous chewing movements induced by haloperidol in rats and has antioxidant potential in vitro.Prevention of haloperidol-induced alterations in brain acetylcholinesterase activity by vitamins B co-administration in a rodent model of tardive dyskinesia.Antioxidant effects of some drugs on ethanol-induced ulcers.Effects of various drugs on alcohol-induced oxidative stress in the liver.Magnesium Supplementation Prevents and Reverses Experimentally Induced Movement Disturbances in Rats: Biochemical and Behavioral Parameters.Cyclooxygenase inhibition attenuates 3-nitropropionic acid-induced neurotoxicity in rats: possible antioxidant mechanisms.Alteration of Cytokines Levels in the Striatum of Rats: Possible Participation in Vacuous Chewing Movements Induced by Antipsycotics.Using superparamagnetic iron oxide nanoparticles to enhance bioavailability of quercetin in the intact rat brain
P2860
Q34625174-F4708246-964E-42C4-8C8A-7145B2195508Q36460613-9594B016-BEDB-420C-AE8D-2163ECAF517FQ37416345-5B8C71B4-09CF-43C4-8361-1256BD4ABC13Q38206130-205149E3-F7E7-4F94-805B-3F5C2A268663Q39279185-C1BAF7BA-41CC-479E-BFF9-CACD68C5EDE5Q40324932-F2A48B6B-CE46-4C55-8057-3BAB6987EE42Q41975964-B00E0B3E-539C-4723-8418-C7311E0117FCQ42212454-7169076C-80C5-492F-AF16-F206EDD7FB9FQ42685864-D92BEB67-F3B8-4D8F-83F9-B14D2A0138EEQ45985326-33FF14F4-14D9-4C0F-8461-360D21B75183Q46102840-5B5E8648-2218-4B85-AA6E-E29787BC83B0Q46335959-69D283E8-8788-43F1-AD02-6129B71A31CCQ46771862-B6A63A5E-D982-40F4-8DD8-B832C902FA0BQ48158835-E2FF9D1F-306B-4B72-AF0B-A96E30202468Q48711490-EC48171F-93DE-499C-8E95-04ECC6833398Q58698278-234F0C1A-AA06-4F93-8BE0-B94943A911F8
P2860
Quercetin, a bioflavonoid, attenuates haloperidol-induced orofacial dyskinesia.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Quercetin, a bioflavonoid, attenuates haloperidol-induced orofacial dyskinesia.
@en
Quercetin, a bioflavonoid, attenuates haloperidol-induced orofacial dyskinesia.
@nl
type
label
Quercetin, a bioflavonoid, attenuates haloperidol-induced orofacial dyskinesia.
@en
Quercetin, a bioflavonoid, attenuates haloperidol-induced orofacial dyskinesia.
@nl
prefLabel
Quercetin, a bioflavonoid, attenuates haloperidol-induced orofacial dyskinesia.
@en
Quercetin, a bioflavonoid, attenuates haloperidol-induced orofacial dyskinesia.
@nl
P2093
P1433
P1476
Quercetin, a bioflavonoid, attenuates haloperidol-induced orofacial dyskinesia.
@en
P2093
Amanpreet Singh
Pattipati S Naidu
Shrinivas K Kulkarni
P304
P356
10.1016/S0028-3908(03)00101-1
P577
2003-06-01T00:00:00Z